ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

NUVB Panacea Acquisition Corp

3.25
-0.02 (-0.61%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Panacea Acquisition Corp NUVB NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.02 -0.61% 3.25 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.38 3.19 3.43 3.22 3.27
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202409:01BWNuvation Bio to Present Updated Data on Taletrectinib, a..
10/4/202415:01BWNuvation Bio Completes Acquisition of AnHeart Therapeutics
28/3/202407:00BWNuvation Bio Announces Appointment of Colleen Sjogren as..
25/3/202406:00BWNuvation Bio to Acquire AnHeart Therapeutics in All-Stock..
14/3/202415:05BWNuvation Bio Doses First Patient in Phase 1/2 Study of..
04/3/202416:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:48EDGAR2Form 8-K - Current report
29/2/202415:01BWNuvation Bio Reports Fourth Quarter and Full Year 2023..
10/1/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202415:58DJNNuvation Bio Gets New Drug Application Clearance From FDA..
08/1/202415:17EDGAR2Form 8-K - Current report
08/1/202415:10BWNuvation Bio Announces Appointment of Dr. Robert Mashal to..
08/1/202415:05BWNuvation Bio Announces FDA Clearance of Investigational New..
14/12/202315:02EDGAR2Form 8-K - Current report
27/11/202315:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/11/202315:01EDGAR2Form 8-K - Current report
13/11/202315:11EDGAR2Form 8-K - Current report
13/11/202315:05BWNuvation Bio Announces Departure of Chief Financial Officer
02/11/202315:23EDGAR2Form 8-K - Current report
02/11/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:10BWNuvation Bio Reports Third Quarter 2023 Financial Results..
03/8/202316:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:17EDGAR2Form 8-K - Current report
03/8/202315:10BWNuvation Bio Reports Second Quarter 2023 Financial Results..
01/6/202315:05BWNuvation Bio Announces Formation of Oncology-Focused..

Su Consulta Reciente

Delayed Upgrade Clock